CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress

  1. Shah, M.
  2. Grothey, A.
  3. Tebbutt, N.
  4. Xu, R.
  5. Yoshino, T.
  6. Cervantes, A.
  7. Tabernero, J.
  8. Taieb, J.
  9. Falcone, A.
  10. Xu, B.
  11. Fontaine, M.
  12. Borodyansky, L.
  13. Van Cutsem, E.
Revue:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Année de publication: 2018

Volumen: 29

Pages: v84

Type: Article

DOI: 10.1093/ANNONC/MDY151.296 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus